CITIUS ONCOLOGY, INC. Quarterly Return On Equity in % from Q4 2023 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Citius Oncology, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2023 to Q3 2024.
  • Citius Oncology, Inc. Return On Equity for the quarter ending September 30, 2024 was -219 %.
  • Citius Oncology, Inc. annual Return On Equity for 2024 was -219 %, a 637% decline from 2023.
  • Citius Oncology, Inc. annual Return On Equity for 2023 was 40.8 %, a 879% increase from 2022.
Return On Equity, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -219 Jul 1, 2024 Sep 30, 2024
Q2 2024 42.8 Apr 1, 2024 Jun 30, 2024
Q1 2024 43.6 Jan 1, 2024 Mar 31, 2024
Q4 2023 40.8 Oct 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.